Stay updated with breaking news from Daniel Scoles. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Scientists at University of Utah Health made a discovery that could lead to a new way to treat Parkinson's disease and potentially stop its progression.
Chemical compound reduces alpha-synuclein, cell stress.
University of Utah Health scientists have identified a molecule that slows cells’ production of alpha-synuclein, a protein that forms toxic aggregates in the brains of people with Parkinson’s disease.
Targeting brain protein may lead to new therapeutic approaches for neurodegenerative disorders Neurological disorders are the number one cause of disability in the world, leading to seven million deaths each year. Yet few treatments exist for these diseases, which progressively diminish a person's ability to move and think. Now, a new study suggests that some of these neurological disorders share a common underlying thread. Staufen1, a protein that accumulates in the brains of patients with certain neurological conditions, is linked to amyotrophic lateral sclerosis (ALS), or Lou Gehrig's dise...
E-Mail Neurological disorders are the number one cause of disability in the world, leading to seven million deaths each year. Yet few treatments exist for these diseases, which progressively diminish a person's ability to move and think. Now, a new study suggests that some of these neurological disorders share a common underlying thread. Staufen1, a protein that accumulates in the brains of patients with certain neurological conditions, is linked to amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, along with other neurological disorders, including Alzheimer's, Parkinson's, and ...